BSGM Company Profile and Key Details
BioSig Technologies
Price Chart
Stock Price Today
BioSig Technologies, Inc. (BSGM) stock surged +37.08%, trading at $6.10 on NASDAQ, up from the previous close of $4.45. The stock opened at $4.44, fluctuating between $4.36 and $6.12 in the recent session.
Stock Snapshot
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2025 | 6.37 | 6.67 | 6.12 | 6.40 | 970.08K |
| Sep 15, 2025 | 6.29 | 6.41 | 5.62 | 5.91 | 1.05M |
| Sep 11, 2025 | 4.36 | 6.12 | 4.36 | 6.10 | 3.14M |
| Sep 10, 2025 | 4.11 | 4.65 | 4.09 | 4.45 | 1.25M |
| Sep 09, 2025 | 3.94 | 4.23 | 3.83 | 4.11 | 701.74K |
| Sep 08, 2025 | 4.33 | 4.50 | 3.81 | 3.88 | 1.46M |
| Sep 05, 2025 | 4.60 | 4.71 | 4.21 | 4.41 | 895.31K |
| Sep 04, 2025 | 4.67 | 4.85 | 4.40 | 4.57 | 686.41K |
| Sep 03, 2025 | 4.70 | 4.84 | 4.52 | 4.71 | 528.5K |
| Sep 02, 2025 | 4.69 | 4.90 | 4.56 | 4.73 | 667.12K |
| Aug 29, 2025 | 5.07 | 5.07 | 4.74 | 4.78 | 376.78K |
| Aug 28, 2025 | 4.80 | 5.19 | 4.76 | 4.92 | 510.84K |
| Aug 27, 2025 | 5.27 | 5.35 | 4.76 | 4.78 | 538.6K |
| Aug 26, 2025 | 5.30 | 5.65 | 5.18 | 5.27 | 699.2K |
| Aug 25, 2025 | 5.10 | 5.63 | 5.10 | 5.30 | 634.43K |
| Aug 22, 2025 | 4.92 | 5.37 | 4.84 | 5.18 | 509.1K |
| Aug 21, 2025 | 4.65 | 5.13 | 4.65 | 4.99 | 695.3K |
| Aug 20, 2025 | 4.88 | 4.93 | 4.40 | 4.72 | 600.33K |
| Aug 19, 2025 | 5.40 | 5.59 | 4.74 | 4.81 | 1.57M |
| Aug 18, 2025 | 4.81 | 5.49 | 4.66 | 5.48 | 1.97M |
Contact Details
About Company
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Company Information
| Employees | 5 |
| Beta | 1.82 |
| Sales or Revenue | $18.00K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Stock Peers
Technical Performance
Earnings & Analyst Outlook
Frequently Asked Questions
Chief Financial Officer
Ms. Brenda Castrodad
Vice President of HR
Mr. Steven Chaussy CPA
Chief Financial Officer
Mr. John Sieckhaus
Chief Operating Officer
Dr. Budimir S. Drakulic Ph.D.
Chief Scientist
Mr. Andrew Gornell Ballou
Vice President of Investor Relations
Mr. Michael Graydon Fleming Jr.
Chief Commercial Officer
Mr. Kenneth L. Londoner M.B.A., MBA
Founder, Chief Executive Officer & Executive Chairman
Mr. Gray Fleming Jr.
Chief Commercial Officer
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep